172 related articles for article (PubMed ID: 27399089)
1. Racial patterns of patients with primary mediastinal large B-cell lymphoma: SEER analysis.
Liu PP; Wang KF; Xia Y; Bi XW; Sun P; Wang Y; Li ZM; Jiang WQ
Medicine (Baltimore); 2016 Jul; 95(27):e4054. PubMed ID: 27399089
[TBL] [Abstract][Full Text] [Related]
2. Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.
Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):126-132. PubMed ID: 26547384
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
4. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
5. Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma.
MacDougall K; Day S; Hall S; Zhao D; Pandey M; Ibrahimi S; Khawandanah M; Chakrabarty JH; Asch A; Nipp R; Al-Juhaishi T
Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):379-384. PubMed ID: 36813625
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
Shenoy PJ; Malik N; Nooka A; Sinha R; Ward KC; Brawley OW; Lipscomb J; Flowers CR
Cancer; 2011 Jun; 117(11):2530-40. PubMed ID: 24048801
[TBL] [Abstract][Full Text] [Related]
7. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
Xiao M; Lin J; Xiao T; Lin Y; Ye Y
Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
[TBL] [Abstract][Full Text] [Related]
8. Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review.
Crozier JA; Sher T; Yang D; Swaika A; Foran J; Ghosh R; Tun H; Colon-Otero G; Kelly K; Chanan-Khan A; Ailawadhi S
Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):578-85. PubMed ID: 26198444
[TBL] [Abstract][Full Text] [Related]
9. Survival in advanced diffuse large B-cell lymphoma in pre- and post-rituximab Eras in the United States.
Shah BK; Bista A; Shafii B
Anticancer Res; 2014 Sep; 34(9):5117-20. PubMed ID: 25202101
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
Griffiths R; Gleeson M; Knopf K; Danese M
BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
[TBL] [Abstract][Full Text] [Related]
11. Childhood cancer among Alaska Natives.
Lanier AP; Holck P; Ehrsam Day G; Key C
Pediatrics; 2003 Nov; 112(5):e396. PubMed ID: 14595083
[TBL] [Abstract][Full Text] [Related]
12. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
[TBL] [Abstract][Full Text] [Related]
13. Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.
Adams SV; Newcomb PA; Shustov AR
J Clin Oncol; 2016 Mar; 34(9):963-71. PubMed ID: 26962200
[TBL] [Abstract][Full Text] [Related]
14. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):699-708.e5. PubMed ID: 31494062
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features and prognosis of primary mediastinal large B-cell lymphoma: a series of sixty cases].
Liu HY; Zhong RQ; Zhang KP; Zhu TN; Zhong DR
Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1139-1144. PubMed ID: 34619867
[No Abstract] [Full Text] [Related]
18. Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.
Lei Y; Huang Q; Li X; Zheng X; Liu M
Medicine (Baltimore); 2022 Jan; 101(3):e28539. PubMed ID: 35060511
[TBL] [Abstract][Full Text] [Related]
19. Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.
Ostrom QT; Cote DJ; Ascha M; Kruchko C; Barnholtz-Sloan JS
JAMA Oncol; 2018 Sep; 4(9):1254-1262. PubMed ID: 29931168
[TBL] [Abstract][Full Text] [Related]
20. Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling.
Yuan J; Wright G; Rosenwald A; Steidl C; Gascoyne RD; Connors JM; Mottok A; Weisenburger DD; Greiner TC; Fu K; Smith L; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Ott G; Vose JM; Staudt LM; Chan WC;
Am J Surg Pathol; 2015 Oct; 39(10):1322-30. PubMed ID: 26135560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
